Review



mic50 mic90bacteria m8 cu o m8 ni o m8 cu o m8 ni o  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    ATCC mic50 mic90bacteria m8 cu o m8 ni o m8 cu o m8 ni o
    Mic50 Mic90bacteria M8 Cu O M8 Ni O M8 Cu O M8 Ni O, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 72 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic50/Scopulariopsis+sp/pm41456004-148-0-23
    Average 94 stars, based on 72 article reviews
    mic50 mic90bacteria m8 cu o m8 ni o m8 cu o m8 ni o - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    other:

    Article Title: Naturally Occurring Isocoumarins Derivatives from Endophytic Fungi: Sources, Isolation, Structural Characterization, Biosynthesis, and Biological Activities
    Article Snippet: Compound Name Biological Activity Assay, Organism, orCell Line Biological Results Positive Control References Exserolide F (201) Antibacterial Colorimetric broth microdilution/B. subtilis (ATCC 6633 20 μg/mL (MIC) Ampicillin 1.25 μg/mL (MIC) [60] Antibacterial S. aureus (CGMCC 1.2465) 5 μg/mL (MIC) Ampicillin 0.16 μg/mL (MIC) [60] Antibacterial S. pneumoniae (CGMCC1.1692) 10 μg/mL (MIC) Ampicillin 10 μg/mL (MIC) [60] Antibacterial E. coli (CGMCC 1.2340) 20 μg/mL (MIC) Gentamicin 2.5 μg/mL (MIC) [60] Isocitreoisocoumarinol (202) Antioxidant Luciferase 0.98 mM (IC50) tBHQ 4.29 mM (IC50) [65] (+) Citreoisocoumarin (203) Antioxidant Luciferase 1.03 mM (IC50) tBHQ 4.29 mM (IC50) [65] (+)-6-Methylcitreoisocoumarin (204) α-Glucosidase inhibitory Chromogenic 38% Inhibition (200 μM) Acarbose 19% Inhibition (200 μM) [31] Antioxidant Luciferase 0.98 mM (IC50) tBHQ 4.29 mM (IC50) [65] Citreoisocoumarinol (205) Antioxidant Luciferase 0.91 mM (IC50) tBHQ 4.29 mM (IC50) [65] Mucorisocoumarin A (207) Antioxidant Luciferase 0.88 mM (IC50) tBHQ 4.29 mM (IC50) [65] Mucorisocoumarin B (208) Antioxidant Luciferase 1.03 mM (IC50) tBHQ 4.29 mM (IC50) [65] Peyroisocoumarin A (209) Antioxidant Luciferase 1.93 mM (IC50) tBHQ 4.29 mM (IC50) [65] Peyroisocoumarin B (210) Antioxidant Luciferase 2.95 mM (IC50) tBHQ 4.29 mM (IC50) [65] Peyroisocoumarin C (211) Antioxidant Luciferase 1.46 mM (IC50) tBHQ 4.29 mM (IC50) [65] Aspergillumarin A (212) α-Glucosidase inhibitory Chromogenic 38.1 μM (IC50) Acarbose 958.3 μM (IC50) [62] Antibacterial Colorimetric broth microdilution/S. albus (ATCC 8799) 12.5 μM (MIC50) Ciprofloxacin 0.312 μM (MIC50) [52] Aspergillumarin B (213) α-Glucosidase inhibitory Chromogenic 193.1 μM (IC50) Acarbose 958.3 μM (IC50) [62] Antibacterial Colorimetric broth microdilution/S. albus (ATCC 8799) 12.5 μM (MIC50) Ciprofloxacin 0.312 μM (MIC50) [52] Molecules 2020, 25, 395 82 of 94 Table 2.

    Article Title: Naturally Occurring Isocoumarins Derivatives from Endophytic Fungi: Sources, Isolation, Structural Characterization, Biosynthesis, and Biological Activities
    Article Snippet: Compound Name Biological Activity Assay, Organism, orCell Line Biological Results Positive Control References (3R,4R)-4,7-Dihydroxymellein (37) Antifungal Direct Bioautography Overlay/Cladosporium cladosporioides 5 μg (Minimum amount required for inhibition of fungi growth on TLC plates) Nystatin 1 μg (Minimum amount required for inhibition of fungi growth on TLC plates) [17] Antifungal Direct Bioautography Overlay/Cladosporium sphaerospermum 10 μg (Minimum amount required for inhibition of fungi growth on TLC plates) Nystatin 1 μg (Minimum amount required for inhibition of fungi growth on TLC plates) [17] Acetylcholinesterase inhibitory TLC-based AChE inhibition 10 μg (IC) Galantamine 1μg (IC) [17] Periplanetin A (39) Antivirus Spectrophotometer/Anti-TMV 14.6% GI (20 μM) Ningnanmycin 28.6% GI(20 μM) [44] (3R)-Methyl-8-hydroxy-6(hydroxymethyl)-7methoxydihydroisocoumarin (40) Antiviral Spectrophotometer/Anti-TMV 21.8% GI (20 μM) Ningnanmycin 32.8% GI(20 μM) [112] (3R)-Methyl-7,8-dimethoxy-6(hydroxymethyl) dihydroisocoumarin (41) Antiviral Spectrophotometer/Anti-TMV 18.6% GI (20 μM) Ningnanmycin 32.8% GI(20 μM) [112] S-(-)-5-Hydroxy-8-methoxy-4-(1′hydroxyethyl)-isocoumarin (54) α-Glucosidase inhibitory Chromogenic 537.3 μM (IC50) Acarbose 958.3 μM (IC50) [62] S-(-)-5,6,8-Trihydroxy-4(1′-hydroxyethyl)isocoumarin (65) α-Glucosidase inhibitory Chromogenic 315.3 μM (IC50) Acarbose 958.3 μM (IC50) [62] Antibacterial Colorimetric broth microdilution/S. aureus (ATCC 27154) 12.5 μM (MIC50) Ciprofloxacin 0.160 μM (MIC50) [52] Antibacterial Colorimetric broth microdilution/B. cereus (ACCC 11077) 6.25 μM (MIC50) Ciprofloxacin 0.625 μM (MIC50) [52] Antibacterial Colorimetric broth microdilution/Vibrio parahemolyticus (ATCC17802) 6.25 μM (MIC50) Ciprofloxacin 0.160 μM (MIC50) [52] Sescandelin (66) α-Glucosidaseinhibitory Chromogenic 417.8 μM (IC50) Acarbose 958.3 μM (IC50) [62] Molecules 2020, 25, 395 75 of 94 Table 2.

    Activity Assay:

    Article Title: Diarylureas: New Promising Small Molecules against Streptococcus mutans for the Treatment of Dental Caries.
    Article Snippet: .. O SF5N H N H F5S Cl O SF5N H N H F5S Cl O SF5N H N H F5S O N H N H 5 5 O N H N H SF5F5S O N H N H Cl Cl SF5F5S Pujol et al., 2018 [105] Antibiotics 2023, 12, x FOR PEER REVIEW 8 of 12 5 Pujol et al. 2018 [105] - H gh activity against wild- type S. mutans CECT 479 (ATCC 25175) with MIC50 = 0.5 μg/mL. ..

    Concentration Assay:

    Article Title: Protective Effect of Procyanidin-Rich Grape Seed Extract against Gram-Negative Virulence Factors.
    Article Snippet: Antibacterial activity of procyanidins-rich grape seed extract against S. Typhimurium ATCC 14028 and E. coli ATCC 25922 planktonic cells. .. GM MIC50 (μg/mL) GM MIC90 (μg/mL) GM MIC100 (μg/mL) S.Typhimurium ATCC 14028 44.17 88.39 222.73 E. coli ATCC 25922 55.68 99.21 396.85 MIC50 = minimum inhibitory concentration of 50% bacterial growth; MIC90 = minimum inhibitory concentration of 90% bacterial growth; MIC100 = minimum inhibitory concentration of 100% bacterial growth; GM = geometric mean. ..

    Article Title: Synthesis, structure-activity relationship and evaluation of antifungal activity of tryptanthrin derivatives against drug-resistant Candida albicans
    Article Snippet: MIC50(ug/mL) FICIe SC5314b ATCC 14053c SC53 14 ATCC 14053 SC5314 ATCC 14053 SC5314 ATCC 14053 FLCa 1.48 > 200 -- -- 4b + FLC 1.51 > 200 1.03 -- 3a-3n > 200 > 200 -- -- 4c + FLC 2.05 > 200 1.40 -- 4a-4n > 200 > 200 -- -- 4d + FLC 1.25 1.86 0.85 0.01 5a > 200 188.76 -- -- 4e + FLC 2.11 > 200 1.56 -- 5b > 200 99.28 -- -- 4f + FLC 2.28 > 200 1.68 -- 5c > 200 94.91 -- -- 4g + FLC 2.39 1.43 1.60 0.01 5d 85.20 79.44 -- -- 4h + FLC 1.97 2.87 1.46 0.01 5e > 200 100.00 -- -- 4i + FLC 3.63 > 200 2.67 -- 5f 87.63 98.92 -- -- 4j + FLC 2.03 2.76 1.49 0.01 5g-5h, 5j-5l > 200 > 200 -- -- 4k + FLC 1.71 > 200 1.26 -- 3a + FLC 1.40 12.70 0.95 0.06 4l + FLC 1.10 3.25 1.028 0.016 3b + FLC > 200 11.19 271.27 0.06 4m + FLC 1.37 3.72 1.281 0.019 3c + FLC > 200 19.71 271.27 0.10 4n + FLC 1.31 15.44 1.221 0.077 3d + FLC > 200 2.43 271.27 0.01 5a + FLC 1.23 4.60 1.148 0.023 3e + FLC > 200 59.64 271.27 0.30 5b + FLC 0.86 0.94 0.798 0.005 3f + FLC 2.76 1.28 1.87 0.01 5c + FLC 0.90 1.00 0.837 0.005 3g + FLC 1.47 43.57 1.00 0.22 5d + FLC 1.05 2.33 0.984 0.012 Page 6/21 Compd. .. MIC50(ug/mL) FICIe SC5314b ATCC 14053c SC53 14 ATCC 14053 SC5314 ATCC 14053 SC5314 ATCC 14053 3h + FLC > 200 > 200 271.27 -- 5e + FLC 1.12 1.10 1.041 0.006 3i + FLC > 200 > 200 271.27 -- 5f + FLC 1.08 2.82 1.016 0.014 3j + FLC > 200 > 200 271.27 -- 5g + FLC 0.91 1.83 0.857 0.009 3k + FLC 1.93 > 200 1.31 -- 5h + FLC 1.08 2.87 1.010 0.014 3l + FLC > 200 > 200 -- -- 5j + FLC 1.57 2.31 1.459 0.012 3m + FLC > 200 > 200 -- -- 5k + FLC 0.92 2.30 0.857 0.012 3n + FLC > 200 1.54 -- 1.05 5l + FLC 0.88 2.40 0.820 0.012 4a + FLC 1.02 1.84 0.69 0.01 aFLC: uconazol;bSC5314: FLC-sensitive C. albicans strain SC5314; cATCC14053: FLC-resistant C. albicans strains ATCC14053; dMIC50: the lowest concentration that exhibited more than 50% growth inhibition of the C. albicans growth relative to the growth control growth; eFICI: the fractional combination of antifungal agent pairs to achieve growth inhibition, synergy was de ned as FICI ≤ 0.5, 0.5 < FICI < 4.0 indicated indifference, and antagonism was de ned as FICI > 4.0. .. MIC50(ug/mL) FICIe SC5314b ATCC 14053c SC53 14 ATCC 14053 SC5314 ATCC 14053 SC5314 ATCC 14053 3h + FLC > 200 > 200 271.27 -- 5e + FLC 1.12 1.10 1.041 0.006 3i + FLC > 200 > 200 271.27 -- 5f + FLC 1.08 2.82 1.016 0.014 3j + FLC > 200 > 200 271.27 -- 5g + FLC 0.91 1.83 0.857 0.009 3k + FLC 1.93 > 200 1.31 -- 5h + FLC 1.08 2.87 1.010 0.014 3l + FLC > 200 > 200 -- -- 5j + FLC 1.57 2.31 1.459 0.012 3m + FLC > 200 > 200 -- -- 5k + FLC 0.92 2.30 0.857 0.012 3n + FLC > 200 1.54 -- 1.05 5l + FLC 0.88 2.40 0.820 0.012 4a + FLC 1.02 1.84 0.69 0.01 aFLC: uconazol;bSC5314: FLC-sensitive C. albicans strain SC5314; cATCC14053: FLC-resistant C. albicans strains ATCC14053; dMIC50: the lowest concentration that exhibited more than 50% growth inhibition of the C. albicans growth relative to the growth control growth; eFICI: the fractional combination of antifungal agent pairs to achieve growth inhibition, synergy was de ned as FICI ≤ 0.5, 0.5 < FICI < 4.0 indicated indifference, and antagonism was de ned as FICI > 4.0.

    Inhibition:

    Article Title: Synthesis, structure-activity relationship and evaluation of antifungal activity of tryptanthrin derivatives against drug-resistant Candida albicans
    Article Snippet: MIC50(ug/mL) FICIe SC5314b ATCC 14053c SC53 14 ATCC 14053 SC5314 ATCC 14053 SC5314 ATCC 14053 FLCa 1.48 > 200 -- -- 4b + FLC 1.51 > 200 1.03 -- 3a-3n > 200 > 200 -- -- 4c + FLC 2.05 > 200 1.40 -- 4a-4n > 200 > 200 -- -- 4d + FLC 1.25 1.86 0.85 0.01 5a > 200 188.76 -- -- 4e + FLC 2.11 > 200 1.56 -- 5b > 200 99.28 -- -- 4f + FLC 2.28 > 200 1.68 -- 5c > 200 94.91 -- -- 4g + FLC 2.39 1.43 1.60 0.01 5d 85.20 79.44 -- -- 4h + FLC 1.97 2.87 1.46 0.01 5e > 200 100.00 -- -- 4i + FLC 3.63 > 200 2.67 -- 5f 87.63 98.92 -- -- 4j + FLC 2.03 2.76 1.49 0.01 5g-5h, 5j-5l > 200 > 200 -- -- 4k + FLC 1.71 > 200 1.26 -- 3a + FLC 1.40 12.70 0.95 0.06 4l + FLC 1.10 3.25 1.028 0.016 3b + FLC > 200 11.19 271.27 0.06 4m + FLC 1.37 3.72 1.281 0.019 3c + FLC > 200 19.71 271.27 0.10 4n + FLC 1.31 15.44 1.221 0.077 3d + FLC > 200 2.43 271.27 0.01 5a + FLC 1.23 4.60 1.148 0.023 3e + FLC > 200 59.64 271.27 0.30 5b + FLC 0.86 0.94 0.798 0.005 3f + FLC 2.76 1.28 1.87 0.01 5c + FLC 0.90 1.00 0.837 0.005 3g + FLC 1.47 43.57 1.00 0.22 5d + FLC 1.05 2.33 0.984 0.012 Page 6/21 Compd. .. MIC50(ug/mL) FICIe SC5314b ATCC 14053c SC53 14 ATCC 14053 SC5314 ATCC 14053 SC5314 ATCC 14053 3h + FLC > 200 > 200 271.27 -- 5e + FLC 1.12 1.10 1.041 0.006 3i + FLC > 200 > 200 271.27 -- 5f + FLC 1.08 2.82 1.016 0.014 3j + FLC > 200 > 200 271.27 -- 5g + FLC 0.91 1.83 0.857 0.009 3k + FLC 1.93 > 200 1.31 -- 5h + FLC 1.08 2.87 1.010 0.014 3l + FLC > 200 > 200 -- -- 5j + FLC 1.57 2.31 1.459 0.012 3m + FLC > 200 > 200 -- -- 5k + FLC 0.92 2.30 0.857 0.012 3n + FLC > 200 1.54 -- 1.05 5l + FLC 0.88 2.40 0.820 0.012 4a + FLC 1.02 1.84 0.69 0.01 aFLC: uconazol;bSC5314: FLC-sensitive C. albicans strain SC5314; cATCC14053: FLC-resistant C. albicans strains ATCC14053; dMIC50: the lowest concentration that exhibited more than 50% growth inhibition of the C. albicans growth relative to the growth control growth; eFICI: the fractional combination of antifungal agent pairs to achieve growth inhibition, synergy was de ned as FICI ≤ 0.5, 0.5 < FICI < 4.0 indicated indifference, and antagonism was de ned as FICI > 4.0. .. MIC50(ug/mL) FICIe SC5314b ATCC 14053c SC53 14 ATCC 14053 SC5314 ATCC 14053 SC5314 ATCC 14053 3h + FLC > 200 > 200 271.27 -- 5e + FLC 1.12 1.10 1.041 0.006 3i + FLC > 200 > 200 271.27 -- 5f + FLC 1.08 2.82 1.016 0.014 3j + FLC > 200 > 200 271.27 -- 5g + FLC 0.91 1.83 0.857 0.009 3k + FLC 1.93 > 200 1.31 -- 5h + FLC 1.08 2.87 1.010 0.014 3l + FLC > 200 > 200 -- -- 5j + FLC 1.57 2.31 1.459 0.012 3m + FLC > 200 > 200 -- -- 5k + FLC 0.92 2.30 0.857 0.012 3n + FLC > 200 1.54 -- 1.05 5l + FLC 0.88 2.40 0.820 0.012 4a + FLC 1.02 1.84 0.69 0.01 aFLC: uconazol;bSC5314: FLC-sensitive C. albicans strain SC5314; cATCC14053: FLC-resistant C. albicans strains ATCC14053; dMIC50: the lowest concentration that exhibited more than 50% growth inhibition of the C. albicans growth relative to the growth control growth; eFICI: the fractional combination of antifungal agent pairs to achieve growth inhibition, synergy was de ned as FICI ≤ 0.5, 0.5 < FICI < 4.0 indicated indifference, and antagonism was de ned as FICI > 4.0.

    Control:

    Article Title: Synthesis, structure-activity relationship and evaluation of antifungal activity of tryptanthrin derivatives against drug-resistant Candida albicans
    Article Snippet: MIC50(ug/mL) FICIe SC5314b ATCC 14053c SC53 14 ATCC 14053 SC5314 ATCC 14053 SC5314 ATCC 14053 FLCa 1.48 > 200 -- -- 4b + FLC 1.51 > 200 1.03 -- 3a-3n > 200 > 200 -- -- 4c + FLC 2.05 > 200 1.40 -- 4a-4n > 200 > 200 -- -- 4d + FLC 1.25 1.86 0.85 0.01 5a > 200 188.76 -- -- 4e + FLC 2.11 > 200 1.56 -- 5b > 200 99.28 -- -- 4f + FLC 2.28 > 200 1.68 -- 5c > 200 94.91 -- -- 4g + FLC 2.39 1.43 1.60 0.01 5d 85.20 79.44 -- -- 4h + FLC 1.97 2.87 1.46 0.01 5e > 200 100.00 -- -- 4i + FLC 3.63 > 200 2.67 -- 5f 87.63 98.92 -- -- 4j + FLC 2.03 2.76 1.49 0.01 5g-5h, 5j-5l > 200 > 200 -- -- 4k + FLC 1.71 > 200 1.26 -- 3a + FLC 1.40 12.70 0.95 0.06 4l + FLC 1.10 3.25 1.028 0.016 3b + FLC > 200 11.19 271.27 0.06 4m + FLC 1.37 3.72 1.281 0.019 3c + FLC > 200 19.71 271.27 0.10 4n + FLC 1.31 15.44 1.221 0.077 3d + FLC > 200 2.43 271.27 0.01 5a + FLC 1.23 4.60 1.148 0.023 3e + FLC > 200 59.64 271.27 0.30 5b + FLC 0.86 0.94 0.798 0.005 3f + FLC 2.76 1.28 1.87 0.01 5c + FLC 0.90 1.00 0.837 0.005 3g + FLC 1.47 43.57 1.00 0.22 5d + FLC 1.05 2.33 0.984 0.012 Page 6/21 Compd. .. MIC50(ug/mL) FICIe SC5314b ATCC 14053c SC53 14 ATCC 14053 SC5314 ATCC 14053 SC5314 ATCC 14053 3h + FLC > 200 > 200 271.27 -- 5e + FLC 1.12 1.10 1.041 0.006 3i + FLC > 200 > 200 271.27 -- 5f + FLC 1.08 2.82 1.016 0.014 3j + FLC > 200 > 200 271.27 -- 5g + FLC 0.91 1.83 0.857 0.009 3k + FLC 1.93 > 200 1.31 -- 5h + FLC 1.08 2.87 1.010 0.014 3l + FLC > 200 > 200 -- -- 5j + FLC 1.57 2.31 1.459 0.012 3m + FLC > 200 > 200 -- -- 5k + FLC 0.92 2.30 0.857 0.012 3n + FLC > 200 1.54 -- 1.05 5l + FLC 0.88 2.40 0.820 0.012 4a + FLC 1.02 1.84 0.69 0.01 aFLC: uconazol;bSC5314: FLC-sensitive C. albicans strain SC5314; cATCC14053: FLC-resistant C. albicans strains ATCC14053; dMIC50: the lowest concentration that exhibited more than 50% growth inhibition of the C. albicans growth relative to the growth control growth; eFICI: the fractional combination of antifungal agent pairs to achieve growth inhibition, synergy was de ned as FICI ≤ 0.5, 0.5 < FICI < 4.0 indicated indifference, and antagonism was de ned as FICI > 4.0. .. MIC50(ug/mL) FICIe SC5314b ATCC 14053c SC53 14 ATCC 14053 SC5314 ATCC 14053 SC5314 ATCC 14053 3h + FLC > 200 > 200 271.27 -- 5e + FLC 1.12 1.10 1.041 0.006 3i + FLC > 200 > 200 271.27 -- 5f + FLC 1.08 2.82 1.016 0.014 3j + FLC > 200 > 200 271.27 -- 5g + FLC 0.91 1.83 0.857 0.009 3k + FLC 1.93 > 200 1.31 -- 5h + FLC 1.08 2.87 1.010 0.014 3l + FLC > 200 > 200 -- -- 5j + FLC 1.57 2.31 1.459 0.012 3m + FLC > 200 > 200 -- -- 5k + FLC 0.92 2.30 0.857 0.012 3n + FLC > 200 1.54 -- 1.05 5l + FLC 0.88 2.40 0.820 0.012 4a + FLC 1.02 1.84 0.69 0.01 aFLC: uconazol;bSC5314: FLC-sensitive C. albicans strain SC5314; cATCC14053: FLC-resistant C. albicans strains ATCC14053; dMIC50: the lowest concentration that exhibited more than 50% growth inhibition of the C. albicans growth relative to the growth control growth; eFICI: the fractional combination of antifungal agent pairs to achieve growth inhibition, synergy was de ned as FICI ≤ 0.5, 0.5 < FICI < 4.0 indicated indifference, and antagonism was de ned as FICI > 4.0.



    Similar Products

    mic50 mic90bacteria m8 cu o m8 ni o m8 cu o m8 ni o  (ATCC)
    94
    ATCC mic50 mic90bacteria m8 cu o m8 ni o m8 cu o m8 ni o
    Mic50 Mic90bacteria M8 Cu O M8 Ni O M8 Cu O M8 Ni O, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic50/Scopulariopsis+sp/pm41456004-148-0-23
    Average 94 stars, based on 1 article reviews
    mic50 mic90bacteria m8 cu o m8 ni o m8 cu o m8 ni o - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    mic50  (ATCC)
    92
    ATCC mic50
    Mic50, supplied by ATCC, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic50/Babjeviella+inositovora+(Golubev+et+al%2E)+Kurtzman+et+Suzuki/pmc12489032-85-5-14
    Average 92 stars, based on 1 article reviews
    mic50 - by Bioz Stars, 2026-10
    92/100 stars
    		  Buy from Supplier
    e1 s1 mic50  (ATCC)
    94
    ATCC e1 s1 mic50
    E1 S1 Mic50, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic50/Hormoconis+resinae+(Lindau)+von+Arx+et+de+Vries/pm40509932-324-9-2
    Average 94 stars, based on 1 article reviews
    e1 s1 mic50 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    mic50  (Chemie GmbH)
    90
    Chemie GmbH mic50
    Mic50, supplied by Chemie GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic50/mic50/pm39611429-180-17-40
    Average 90 stars, based on 1 article reviews
    mic50 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    compound mic50  (ATCC)
    97
    ATCC compound mic50
    Compound Mic50, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic50/Candida+albicans%3B+SC5314/pmc11467720__RA___014___D4RA06539E___s001-25-15-30
    Average 97 stars, based on 1 article reviews
    compound mic50 - by Bioz Stars, 2026-10
    97/100 stars
    		  Buy from Supplier
    mic50 e coli atcc11775  (ATCC)
    98
    ATCC mic50 e coli atcc11775
    Mic50 E Coli Atcc11775, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic50/Escherichia+coli/pm37515922-235-15-23
    Average 98 stars, based on 1 article reviews
    mic50 e coli atcc11775 - by Bioz Stars, 2026-10
    98/100 stars
    		  Buy from Supplier
    mbc mic50 mic90 mic range mbc range mpall  (ATCC)
    96
    ATCC mbc mic50 mic90 mic range mbc range mpall
    Mbc Mic50 Mic90 Mic Range Mbc Range Mpall, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mic50/Auricularia+fuscosuccinea+(Montagne)+Farlow%2C+teleomorph/pm37570659-88-16-7
    Average 96 stars, based on 1 article reviews
    mbc mic50 mic90 mic range mbc range mpall - by Bioz Stars, 2026-10
    96/100 stars
    		  Buy from Supplier

    Image Search Results